| Naslov: | Patient doses in image-guided radiotherapy: status in Europe for cone-beam CT imaging in the pelvic region |
|---|
| Avtorji: | ID Kansanoja, Toni, Department of Physics, University of Helsinki , Helsingin Yliopisto , Finland Helsinki Institute of Physics , Helsingin Yliopisto , Finland (Avtor)
ID Brovchuk, Serhii, LISOD Israeli Oncology Hospital , Pliuty , Ukraine State Institute “O.O. Shalimov Scientific Center of Surgery and Transplantation” , Kyiv , Ukraine (Avtor)
ID Vezirovic, Milana, Department of Physics, Radiotherapy Department, University of Novi Sad , Novi Sad , Serbia Oncology Institute of Vojvodina , Sremska Kamenica , Serbia (Avtor)
ID Petrovic, Borislava, Department of Physics, Radiotherapy Department, University of Novi Sad , Novi Sad , Serbia Oncology Institute of Vojvodina , Sremska Kamenica , Serbia (Avtor)
ID Amico, Antonio Giuseppe, Medical Physics Department, Veneto Institute of Oncology IOV-IRCCS , Via Gattamelata 64, 35128 Padova , Italy (Avtor)
ID Sapignoli, Sonia, Medical Physics Department, Veneto Institute of Oncology IOV-IRCCS , Via Gattamelata 64, 35128 Padova , Italy (Avtor)
ID Paiusco, Marta, Medical Physics Department, Veneto Institute of Oncology IOV-IRCCS , Via Gattamelata 64, 35128 Padova , Italy (Avtor)
ID Ferrari, Paolo, ENEA, Istituto di Radioprotezione, Radiation Protection Institute , Bologna , Italy (Avtor)
ID Sá, Ana Cravo, Centro de Ciências e TecnologiasNucleares (IST) , Bobadela LRS , Portugal TBIO|RISE-Health, Escola Superior de Saúde - Politécnico Porto , Porto , Portugal (Avtor)
ID Dias, Anabela G, Institute Português de Oncologia do Porto Francisco Gentil (IPOPFG) - Medical Physics Service, R. Dr. António Bernardino de Almeida , Porto , Portugal Medical Physics, Radiobiology and Radiation Protection Group, IPO Porto Research Centre (CI-IPO), Portuguese Oncology Institute of Porto (IPO-Porto), Porto Comprehensive Cancer Center (Porto.CCC) & Rise@CI-IPOP (Health Research Network) , Porto , Portugal (Avtor)
ID Teles, Pedro, Medical Physics, Radiobiology and Radiation Protection Group, IPO Porto Research Centre (CI-IPO), Portuguese Oncology Institute of Porto (IPO-Porto), Porto Comprehensive Cancer Center (Porto.CCC) & Rise@CI-IPOP (Health Research Network) , Porto , Portugal Department of Physics and Astronomy of the Faculty of Sciences of the University of Porto, Rua do Campo Alegre , Porto , Portugal (Avtor)
ID Siiskonen, Teemu, Department of Physics, University of Helsinki , Helsingin Yliopisto , Finland Helsinki Institute of Physics , Helsingin Yliopisto , Finland Radiation and Nuclear Safety Authority (STUK) , Vantaa , Finland (Avtor) |
|---|
| Datoteke: |  URL - Izvorni URL, za dostop obiščite https://www.sciendo.com/pdf/10.2478/raon-2026-0012
 PDF - Predstavitvena datoteka, prenos (908,76 KB)
MD5: 402C202DC92DBEB3D98E77F83BA5E14E
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  DRO - Društvo radiologije in onkologije
|
|---|
| Povzetek: | bstract Background Organ absorbed doses in cone-beam CT (CBCT) imaging are often neglected in image-guided radiation therapy (IGRT). However, frequent imaging for patient positioning can result in significant and unrecorded additional radiation exposure. This study aims to evaluate organ doses from kV-CBCT and assess if they are optimized and how, in prostate and pelvic patient positioning protocols across Europe. Status of quality assurance in IGRT CBCT imaging is assessed in general. Materials and methods Data collected from a survey distributed across Europe on IGRT practices were compiled and analysed. A representative set of imaging protocols were simulated using Monte Carlo based ImpactMC software to assess mean absorbed doses in various organs in the International Commission on Radiological Protection (ICRP) standard phantom. Absorbed doses to red bone marrow were estimated with a three-parameter mass-energy absorption coefficient method. The simulations were validated against measurements with MOSFET detectors and radiochromic film. Results Simulated prostate absorbed doses ranged from 12 mGy to 34 mGy per imaged fraction for pelvic protocols, and 4 mGy to 26 mGy for prostate protocols. The selected length of the imaging region influenced doses to the femur and sacral red bone marrow. Overall, 74% of treatments involved positioning imaging at every fraction, indicating substantial cumulative doses from kV-CBCT imaging. Quality assurance was performed by 90% of responders, but good practice guides and national protocols do not exist. Conclusions The results of this study suggest that clear guidelines and standardized protocols for CBCT imaging in IGRT are lacking. There is significant potential to optimize the patient doses resulting from imaging. Given that most clinics already perform regular quality assurance for imaging equipment, including dosimetry and positioning accuracy verification, establishing diagnostic reference levels for CBCT imaging in IGRT could help promote further dose optimization. |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Datum objave: | 01.03.2026 |
|---|
| Založnik: | Association of Radiology and Oncology |
|---|
| Št. strani: | str. 141-152 |
|---|
| Številčenje: | Vol. 60, no. 1 |
|---|
| Izvor: | Ljubljana |
|---|
| PID: | 20.500.12556/DiRROS-30295  |
|---|
| eISSN: | 1581-3207 |
|---|
| DOI: | 10.2478/raon-2026-0012 |
|---|
| Datum objave v DiRROS: | 18.06.2026 |
|---|
| Število ogledov: | 56 |
|---|
| Število prenosov: | 28 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
